
Biological E. to produce Jiangsu Recbio Tech’s HPV9 vaccine REC603
The Hindu
Biological E. to produce Recbio's HPV9 vaccine in India, expanding global access to cervical cancer prevention.
More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












